Stock Price
260.00
Daily Change
0 0%
Monthly
12.48%
Yearly
-37.24%
Q2 Forecast
247.42

Novo Nordisk reported DKK4.44B in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Bausch Health Companies USD 370.53M 59K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Novo Nordisk DKK 4.44B 0 Dec/2025
Novo Nordisk DKK 4.44B 3.99B Jun/2025
Pacira USD 41.12M 1.85M Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025